Chronic treatment with hydroxychloroquine confers protection against SARS-CoV-2

Chronic treatment with hydroxychloroquine confers protection against SARS-CoV-2

Background: Hydroxychloroquine sulphate (HCQ) is being scrutinized for repositioning in the treatment and prevention of SARS-Cov-2 infection. This antimalarial drug is also chronically used to treat patients with autoimmune diseases. Methods: By analyzing the…

Read More…

You May Also Like